Na-lee Ka
Gwangju, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Tamoxifen promotes metastasis of breast cancer via reshaping lipid-driven fibrotic microenvironments in the lung.
Journal: Neoplasia (New York, N.Y.)
Published: September 21, 2025
Gnetofuran A Enhances Osteoblast Differentiation through the p38 Signaling Pathway.
Journal: Biomolecules & therapeutics
Published: September 21, 2025
IFI16/IFI202 blockade suppresses tumor growth through CD8+ T-cell-mediated immunity.
Journal: Breast cancer research : BCR
Published: September 17, 2025
IFI16 Enhances Chemosensitivity of Breast Cancer Cells by Inhibiting DNA Damage Response.
Journal: Biomolecules & therapeutics
Published: May 06, 2025
Secreted LGALS3BP facilitates distant metastasis of breast cancer.
Journal: Breast cancer research : BCR
Published: August 09, 2024
Targeting HMG-CoA synthase 2 suppresses tamoxifen-resistant breast cancer growth by augmenting mitochondrial oxidative stress-mediated cell death.
Journal: Life sciences
Published: March 30, 2023
NR1D1 Stimulates Antitumor Immune Responses in Breast Cancer by Activating cGAS-STING Signaling.
Journal: Cancer research
Published: January 31, 2023
IFI16/Ifi202 released from breast cancer induces secretion of inflammatory cytokines from macrophages and promotes tumor growth.
Journal: Journal of cellular physiology
Published: November 08, 2022
Type I IFN stimulates IFI16-mediated aromatase expression in adipocytes that promotes E2-dependent growth of ER-positive breast cancer.
Journal: Cellular and molecular life sciences : CMLS
Published: February 20, 2022
High expression of NR1D1 is associated with good prognosis in triple-negative breast cancer patients treated with chemotherapy.
Journal: Breast cancer research : BCR
Published: April 06, 2018
Last Updated: 09/26/2026